Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report)’s share price reached a new 52-week low during trading on Friday . The company traded as low as GBX 58.75 ($0.75) and last traded at GBX 61 ($0.78), with a volume of 56190 shares traded. The stock had previously closed at GBX 66 ($0.85).
Celadon Pharmaceuticals Trading Down 7.6 %
The stock has a market cap of £40.10 million, a price-to-earnings ratio of -478.57 and a beta of -0.02. The business’s fifty day simple moving average is GBX 86.50 and its 200 day simple moving average is GBX 94.88. The company has a debt-to-equity ratio of 148.29, a current ratio of 2.62 and a quick ratio of 6.97.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
Recommended Stories
- Five stocks we like better than Celadon Pharmaceuticals
- Top Stocks Investing in 5G Technology
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
- 3 Healthcare Dividend Stocks to Buy
- This Financial Stock’s Earnings Signal a Buying Opportunity
- Trading Halts Explained
- Social Platform Stock Hits New Highs: Is More Growth Ahead?
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
